Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,142 | -11,091 | 2,816 | 10,193 | 8,067 |
| Cost of Goods | -1,727 | -1,715 | 4,110 | 6,544 | 3,528 |
| Gross Profit | 3,869 | -9,376 | -1,294 | 3,649 | 4,539 |
| Operating Expenses | 15,273 | 12,331 | 89,341 | 17,038 | 18,048 |
| Operating Income | -12,131 | -22,422 | -90,525 | -12,845 | -12,981 |
| Other Income | -406 | -394 | -492 | -4 | 80 |
| Pre-tax Income | -12,537 | -22,816 | -91,017 | -12,849 | -12,901 |
| Income Tax | -823 | -37,277 | 17,608 | -11 | -12 |
| Net Income Continuous | -11,714 | 14,461 | -108,625 | -12,838 | -12,889 |
| Net Income Discontinuous | 1,769 | 9,767 | -2,291 | N/A | N/A |
| Net Income | $-9,945 | $24,228 | $-110,916 | $-12,838 | $-12,889 |
| EPS Basic Total Ops | -296.15 | -450.40 | -2,190.30 | -388.70 | -394.87 |
| EPS Basic Continuous Ops | -345.51 | -628.26 | -2,239.66 | -391.54 | -393.10 |
| EPS Basic Discontinuous Ops | 49.36 | 178.93 | 49.36 | N/A | N/A |
| EPS Diluted Total Ops | -296.15 | -450.40 | -2,190.30 | -388.70 | -394.87 |
| EPS Diluted Continuous Ops | -345.51 | -628.26 | -2,239.66 | -391.54 | -393.10 |
| EPS Diluted Discontinuous Ops | 49.36 | 178.93 | 49.36 | N/A | N/A |
| EBITDA(a) | $-11,290 | $-21,972 | $-89,330 | $-11,964 | $-12,145 |